Factor Bioscience to Showcase Engineered iMacrophages (FACT-112) Targeting Ovarian Cancer In Vivo at ISCT 2026

B – Factor to reveal latest pre-clinical data on FACT-112: engineered iMacrophages for treating solid-tumors CAMBRIDGE, Mass., April 30, 2026 /PRNewswire/ — Factor Bioscience Inc.,…
posteditor
posteditor
Articles: 17424

Other News